.jpg)
We're very excited to lift the lid on our public launch, alongside $5m in seed funding from leading technology and healthcare investors including Firstminute Capital, Presight Capital, Seedcamp, Hambro Perks, Amino Collective, and Calm/Storm!
Our mission stems from the experience of our founding team. Michael was previously a Special Adviser to the UK Prime Minister. Meri was a venture capitalist, investing in healthcare companies. Both are frequent trial participants; Meri took part in one of the Covid vaccine trials, which felt "like stepping into a time machine. This was one of the best funded trials in history but research was done on pen and paper and participants had to go into a hospital at the height of the pandemic to fill out forms." During his time in Government, Michael "heard time and time again that the way clinical trials are conducted is broken. This means that patients are missing out on lifesaving treatments. To fix this requires a totally new business model for clinical trials. So we founded Lindus Health to do just that and to enable the next generation of healthcare companies.”
Over the last 30 years life expectancy in developed countries has stagnated. There have been few, if any, advances in frontline treatments for the majority of common chronic conditions, while pharma are focused on increasingly niche indications. The fundamental cause of all of this is clinical trials.
Clinical trials are the core of healthcare research. They’re needed to assess the safety and efficacy of new treatments. They’re also getting increasingly expensive over time, making new medicines cost exponentially more and limiting the number of new treatments available.
There are two main drivers of this: incumbent organisations, and antiquated technology. The incumbents, like Contract Research Organisations (CROs), are old-fashioned service organisations that operate on a cost-plus business model, outsourcing almost all aspects of trial delivery. This means they have neither the incentive nor the levers to make clinical trials more efficient. In tandem, most trials are labour-intensive and still delivered on pen and paper or use a mess of different technology systems, meaning that costs are high and data quality is poor. The result? The cost of an average clinical trial has roughly doubled every 9 years for the last 50 years; it now costs $1bn to bring a new treatment to market. These costs are passed on to healthcare systems, and ultimately to patients.
We're building the world’s first full stack clinical trial platform, to conduct faster, safer clinical trials, improving health outcomes for everyone. We want to be a one-stop-shop for innovative healthcare companies, handling all aspects of trial design, recruitment and delivery. This would replace either dealing with a mix of academic labs or designing a trial in house and relying on a slow, expensive CRO to deliver. Unlike US players like Medable and Science37 who cater to big pharma, we recognise that biotech and healthtech startups are developing the next generation of exciting treatments. We're building a platform specifically for them.
Despite only having founded the company 6 months ago, we've had a big impact, recruiting over 4,000 patients to 25 clinical trials and studies in areas like type 2 diabetes, depression, cancer and vaccine development.
To continue fulfilling our mission, we're announcing a $5m seed round. Investors include leading European and US investors, Firstminute Capital, Presight Capital, Seedcamp, Hambro Perks, Amino Collective, Calm/Storm Ventures. Angel investors include Mehdi Ghissassi (Deepmind), Alex Zhavoronkov (Insilico Medicine), Marc Warner (Faculty AI), James Dacombe (CoMind), Henry de Zoete (Look After My Bills), and Vishal Gulati (healthtech.vc).
The seed funding will be used to scale our team, with a focus on bringing together the best individuals and practices from both digital technology and life sciences. We're supported by world-class industry advisors, Tamsin Berry (Biotech investor and previously Head of UK Government Life Sciences), and Shaun Treweek (editor of the Trials journal). Early employees include Nik Haldimann (co-founder and CTO), Luke Twelves (primary care lead), and Rebecca de Rome (operations and growth lead).
Whether you're a planning a clinical trial, want to participate in research or just interested in the space, we'd love to hear from you. Get in touch and help us accelerate the development of new treatments!
.png)
Announcing Pilot Trials: clinical data in weeks, not years
Enter pilot trials! We now offer pilot trials for companies who may not need to run a full clinical trial but need data in order to get their product to patients. Sound like it could be you? Read more here.
.jpg)
Why working with a university isn't always best for DTx start-ups
Our Co-Founder Michael explores the best options for DTx startups looking to start generating clinical evidence and why it might not always be best to work with academic institutions.
Product Clinic #5: Lindus Health’s first Hackathon
In July 2022 Lindus Health commenced its first hackathon with everyone in the product team, from data science to our CTO and head of product getting involved.
.png)
Why I joined Lindus Health - Hannah Swayze, Senior Trial Manager
To overcome the current barriers to clinical research; To develop innovative technology that will deliver clinical trials more efficiently; To be a part of a supportive, flexible and growing team.
.jpg)
Product clinic #4: One roadmap to rule all clinical trials
Our product team are agile. What does this mean? It means they move fast, customise quickly and add functionality, all without causing delays. Want to know how? Read here about the ruthless prioritisation that guides our product team.
Product Clinic #3: Embedding software engineering efficiency hacks into our clinical trial platform
Heard of dogfooding? No, not feeding your pet! The practice of using your own software to understand how it performs in the real world and catch any issues. Read about this and other software engineering hacks we are using to build better products.
A Fireside Chat with Paul Wicks: How can we make clinical research for digital therapeutics more patient-friendly?
Digital Therapeutics are still a relatively new treatment area and there is a lot to learn about conducting clinical research on them. Find out how Paul Wick's, Digital Health expert, thinks research companies can put the patients first.
Product Clinic #2: Using feedback loops to build better products
Lindus Health's objective is to build better products that hit non-negotiable clinical standards and challenge outdated conventions. How do we do this? Read more here
Why I joined Lindus Health? Ece Kavalci, Machine Learning Engineer
Working towards a good cause. Innovative approaches to solving problems in clinical trial design. Every contribution is valued.
Why I joined Lindus Health? Van Zyl Engelbrecht
The mission to accelerate clinical trial. The focus on making clinical research more patient-centric. The ability to support innovative health companies bring their product to market at a lower cost.
.jpg)
Product Clinic #1: Turning boring technology into exciting products
Don't be put off by the blunt use of the word "boring" to describe our technology. It's one of our guiding principles allowing us to make rapid progress while maintaining high quality standards. Read more here.
James Lind and the Mafia
The story of how James Lind's trial for scurvy led to the formation of the mafia.
What actually improves diversity in clinical research?
We’ve all seen the evidence of ethnic minority underrepresentation but what is actually going to have an impact in the future? Read Lindus Health’s action plan here
Vaccine Trials and Tribulations
Read co-founder Meri’s experience of a Covid-19 vaccine trial that left him frustrated (but vaccinated), and led to the creation of Lindus Health.
Stagnation, Drugs and Eroom's law
Why does the cost of clinical trials continue to increase? Meri Beckwith, Lindus Health co-founder discusses why stagnation has prevailed and how technology is the answer
Cure Scurvy with this one weird trick…! Doctors hate him
In 1747 James Lind conducted the first clinical trial, proving that oranges and lemons were a cure for scurvy. Given that we’re named after him we felt it was about time we wrote a post about the history of scurvy, Lind, and the first ever clinical trial! We believe that in 100 years current health outcomes will seem just as ridiculous and intolerable as 50% of sailors dying of scurvy seems now, and that’s why we’re named Lindus Health.
Why I joined Lindus Health? Luke Twelves, Medical Lead
To help make trials more accessible to patients and clinicians. To help bring novel and innovative treatments to the frontline of care faster. To stretch myself and work as part of a really exciting team.
.png)
A success story: Lindus Health recruiting prediabetes patients for the ASPIRE-DNA clinical trial
Lindus Health used its multi-channel strategy to accelerate DnaNudge's trial recruitment. Read more about the challenges they faced and our results here.
Why I joined Lindus Health? Nik Haldimann, CTO
A worthy mission. Personal challenge & growth. To create a dream environment for engineers.
Optimising trial recruitment with our Primary Care Network
Primary care organisations are responsible for patient care but are not yet set-up for research. What do we mean by Lindus Health’s Primary Care Network and what are its advantages? Learn how primary care can turbocharge your trial recruitment.
.jpg)